Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1016/s1074-7613(00)80222-8
Read article for free, from open access legal sources, via Unpaywall: http://www.cell.com/article/S1074761300802228/pdf
References
Articles referenced by this article (32)
Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen.
Cell, (4):649-658 1994
MED: 7525079
The MIC gene family
Res. Imunol. 1996
NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals.
Hum Immunol, (1):18-27 2000
MED: 10658974
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Science, (5428):727-729 1999
MED: 10426993
Molecular characterization of rat NKR-P2, a lectin-like receptor expressed by NK cells and resting T cells.
Int Immunol, (4):379-385 1998
MED: 9620593
Natural killer cells in antiviral defense: function and regulation by innate cytokines.
Annu Rev Immunol, 189-220 1999
MED: 10358757
Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
J Exp Med, (5):813-818 1998
MED: 9480992
The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
Eur J Immunol, (5):1164-1169 1997
MED: 9174606
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Nature, (6669):795-799 1998
MED: 9486650
Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.
Proc Natl Acad Sci U S A, (22):12445-12450 1996
MED: 8901601
Show 10 more references (10 of 32)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Article citations
Natural killer cells in cancer immunotherapy.
MedComm (2020), 5(7):e626, 15 Jun 2024
Cited by: 0 articles | PMID: 38882209 | PMCID: PMC11179524
Review Free full text in Europe PMC
Five decades of natural killer cell discovery.
J Exp Med, 221(8):e20231222, 06 Jun 2024
Cited by: 0 articles | PMID: 38842526
Review
Therapeutic avenues for γδ T cells in cancer.
J Immunother Cancer, 11(11):e007955, 24 Nov 2023
Cited by: 4 articles | PMID: 38007241 | PMCID: PMC10680012
Review Free full text in Europe PMC
Phytochemicals as Immunomodulatory Molecules in Cancer Therapeutics.
Pharmaceuticals (Basel), 16(12):1652, 26 Nov 2023
Cited by: 5 articles | PMID: 38139779 | PMCID: PMC10746110
Review Free full text in Europe PMC
Porcine UL-16 Binding Protein 1 Is Not a Functional Ligand for the Human Natural Killer Cell Activating Receptor NKG2D.
Cells, 12(22):2587, 07 Nov 2023
Cited by: 2 articles | PMID: 37998322 | PMCID: PMC10670462
Go to all (443) article citations
Other citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Eur J Immunol, 33(2):381-391, 01 Feb 2003
Cited by: 103 articles | PMID: 12645935
Ligands for murine NKG2D display heterogeneous binding behavior.
Eur J Immunol, 32(3):597-605, 01 Mar 2002
Cited by: 50 articles | PMID: 11857333
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.
Nature, 413(6852):165-171, 01 Sep 2001
Cited by: 607 articles | PMID: 11557981 | PMCID: PMC3900321
Strategies for target cell recognition by natural killer cells.
Immunol Rev, 181:170-184, 01 Jun 2001
Cited by: 130 articles | PMID: 11513138
Review